172 related articles for article (PubMed ID: 3492185)
1. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
Bogusławska-Jaworska J; Rodziewicz B
Arch Immunol Ther Exp (Warsz); 1986; 34(4):392-5. PubMed ID: 3492185
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
3. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
[TBL] [Abstract][Full Text] [Related]
4. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
Leverger G; Bancillon A; Schaison G
Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
[TBL] [Abstract][Full Text] [Related]
5. [T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)].
Wehinger H; Karitzky D
Klin Padiatr; 1977 May; 189(3):234-41. PubMed ID: 301585
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lymphoid leukemia in children: current regimens and future prospects.
Brecher ML
N Y State J Med; 1986 Apr; 86(4):188-96. PubMed ID: 3520409
[No Abstract] [Full Text] [Related]
7. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
Tubiana N; Derre M; Carcassonne Y
Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
10. [Acute lymphoblastic leukemia in children. The use of antisera specific for lymphocyte populations in a classification trial].
Andary M; Clot J; Brochier J; Levallois C; Dossa D; Marguerite G; Jean R
Arch Fr Pediatr; 1979; 36(8):751-9. PubMed ID: 317241
[TBL] [Abstract][Full Text] [Related]
11. [Immunological aspects of acute lymphoblastic leukemia (ALL) in children (author's transl)].
Ritter J
Klin Padiatr; 1978 Sep; 190(5):436-40. PubMed ID: 359912
[TBL] [Abstract][Full Text] [Related]
12. [Lymphoblastic leukemia and immunological markers].
Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
[TBL] [Abstract][Full Text] [Related]
13. [Studies of the immunological profile in acute lymphoblastic leukemia in children].
Esposito L; Guerriero A; Benedetto N; Dell'Aquila P
Pediatria (Napoli); 1979 Jun; 87(2):173-82. PubMed ID: 317666
[No Abstract] [Full Text] [Related]
14. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
Greaves MF; Janossy G; Peto J; Kay H
Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
[TBL] [Abstract][Full Text] [Related]
15. Outcome of biphenotypic acute leukemia.
Killick S; Matutes E; Powles RL; Hamblin M; Swansbury J; Treleaven JG; Zomas A; Atra A; Catovsky D
Haematologica; 1999 Aug; 84(8):699-706. PubMed ID: 10457405
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
Suzuki M
Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of high and low risk acute lymphoblastic leukemias in the child, with 2 modalities of preventive therapy on the central nervous system (Pethema 7/78 protocol)].
Ortega Aramburu JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1985 Nov; 23(6):417-30. PubMed ID: 3867301
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.
Baccarani M; Gobbi M; Tura S
N Engl J Med; 1980 Jan; 302(2):123. PubMed ID: 6965316
[No Abstract] [Full Text] [Related]
19. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
[TBL] [Abstract][Full Text] [Related]
20. Classification and prognosis of acute lymphoblastic leukemia.
Bloomfield CD
Prog Clin Biol Res; 1981; 58():167-83. PubMed ID: 7022480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
